Subject(s)
Cardiomyopathy, Dilated/complications , Eosinophilia/complications , Ventricular Dysfunction, Left/etiology , Chronic Disease , Churg-Strauss Syndrome/diagnosis , Churg-Strauss Syndrome/etiology , Endomyocardial Fibrosis/diagnosis , Endomyocardial Fibrosis/etiology , Humans , Magnetic Resonance Angiography , Male , Middle AgedSubject(s)
Endomyocardial Fibrosis/etiology , Eosinophilia/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , T-Lymphocytes , Adult , Diagnosis, Differential , Endomyocardial Fibrosis/diagnosis , Eosinophilia/diagnosis , Humans , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosisABSTRACT
BACKGROUND: Insulin-like growth factor 1 (IGF-1) promotes favorable cardiac remodeling in heart failure. However, the relation of plasma IGF-1 in patients with various degrees of heart failure is not known. METHODS: Venous plasma samples were collected from patients with clinically documented heart failure (n = 24) and from control subjects (n = 21) for measurements of IGF-1 levels. In the heart failure group, functional assessment of the physical capacity was determined by means of the New York Heart Association (NYHA) score. Objective determination of ventricular performance was made by transthoracic echocardiographic measurement of left ventricular fractional shortening (FS). RESULTS: IGF-1 levels were higher in patients with heart failure (mean age, 67 +/- 2 years; 17 men) than in control subjects (age, 71 +/- 2 years; 9 men) (20.2 +/- 2 mU/L, 14.1 +/- 2 mU/L, respectively, P <.05). However, the elevated IGF-1 levels were demonstrated only in patients with mild-to-moderate symptoms (NYHA classes I and II) of heart failure (24.7 +/- 3.3 mU/L, n = 12, P =.005 vs control subjects) but not in patients with severe symptoms (NYHA classes III and IV) (15.7 +/- 2.3 mU/L, n = 12). There was a strong positive correlation between IGF-1 levels and left ventricular FS (%) (r = 0.58, P =.003, n = 24). Adjustments for other potential confounders including age, sex, treatment received, and underlying cause of heart failure did not alter the relation between IGF-1 and left ventricular FS (odds ratio, 2.01; 95% confidence interval, 1.26 to 6.24; P =.01). CONCLUSIONS: Plasma levels of IGF-1 show distinct variations with the severity of heart failure and may play a vital role in compensated heart failure.
Subject(s)
Heart Failure/blood , Heart Failure/classification , Insulin-Like Growth Factor I/analysis , Aged , Female , Humans , Linear Models , MaleABSTRACT
Arterial embolization of a malignant tumor is extremely rare. We report an unusual case of a young adult man who presented with acute lower limb ischemia and a mass in the right lung and left atrium. These clinical manifestations were the result of metastases and embolization from a germ cell tumor and were the first indication of malignancy in this patient. The importance of appropriate investigations in the subsequent treatment is stressed.
